Embecta Corp

NASDAQ EMBC

Download Data

Embecta Corp Net Working Capital to Total Assets Ratio 1 year YoY Change (%) for the quarter ending March 31, 2024: 1.12%

Embecta Corp Net Working Capital to Total Assets Ratio 1 year YoY Change (%) is 1.12% for the quarter ending March 31, 2024, a -83.00% change year over year. The net working capital to total assets ratio measures the proportion of a company's net working capital (current assets minus current liabilities) to its total assets. It is calculated by dividing the net working capital by the total assets. This ratio indicates the percentage of a company's total assets that are financed by its net working capital. A higher ratio suggests a greater reliance on working capital to fund the company's operations and indicates a potential liquidity cushion. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • Embecta Corp Net Working Capital to Total Assets Ratio for the quarter ending March 31, 2023 was 0.33, a 6.59% change year over year.
  • Embecta Corp Net Working Capital to Total Assets Ratio for the quarter ending March 31, 2022 was 0.31.
NASDAQ: EMBC

Embecta Corp

CEO Mr. Devdatt Kurdikar
IPO Date April 1, 2022
Location United States
Headquarters 300 Kimball Drive, Parsippany, NJ, United States, 07054
Employees 2,200
Sector Healthcare
Industry Medical instruments & supplies
Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Similar companies

ANGO

AngioDynamics Inc

NA

NA

AKYA

Akoya Biosciences Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email